ibrexafungerp

ibrexafungerp Scynexis Announces Submission of New Drug Application to the U.S. Food and Drug Administration for Oral Ibrexafungerp for the Treatment of Vaginal Yeast Infection JERSEY CITY, N.J., Oct. 14, 2020 (GLOBE NEWSWIRE) — SCYNEXIS,